Company profile: AnalytiCon Discovery
1.1 - Company Overview
Company description
- Provider of natural product-based R&D for pharmaceutical, agrochemical, food & beverage, and cosmetic industries, offering drug discovery from plant and microbial biosynthetic products; 25,000-microorganism strain and 20,000 plant partition collections; liquid, solid, and membrane fermentation; high-throughput isolation of pure natural products; and medicinal chemistry optimization and SAR.
Products and services
- Natural Product Chemistry & Drug Discovery: Engineers pharmaceutical leads by researching and developing natural products, focusing on biosynthetic products derived from plants and microorganisms for pharmaceutical applications
- Biosynthetic-focused
- Medicinal Chemistry Optimization: Architects synthesis and executes structure–activity relationship studies to optimize natural product hits or drug candidates through iterative modification and evaluation
- SAR-driven
- High Throughput Isolation Platform: Produces pure natural products via integrated extraction, chromatography, and analytics to isolate compounds from complex matrices
- High-throughput
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to AnalytiCon Discovery
Project Farma
HQ: United States
Website
- Description: Provider of healthcare consulting services to pharmaceutical and medical device manufacturers across the supply chain, including GMP-compliant cell and gene therapy facility builds using modular, bioreactor and single-use technologies; business and manufacturing strategy; turnkey capital projects and project management; validation for GMP/GLP/GCP; quality, regulatory and compliance for ISO/GMP; and engineering and automation solutions.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Project Farma company profile →
Analgesic Solutions
HQ: United States
Website
- Description: Provider of consulting, innovative tools, data science, technology, and training to reduce risks in clinical trials; privately held.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Analgesic Solutions company profile →
Inke
HQ: Spain
Website
- Description: Provider of high-quality active pharmaceutical ingredients (APIs) with sophisticated synthesis procedures, primarily for respiratory and central nervous system (CNS) therapies, including specialized inhalation APIs.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Inke company profile →
EirGen Pharma
HQ: Ireland
Website
- Description: Provider of high potency oral solid dose medicines for human and veterinary use and contract development, manufacturing, and packaging services for the global pharmaceutical market, including research, formulation, and analytical development and investigational medicinal products. Fully licensed to manufacture oncology, cytotoxic, steroidal, and immunosuppressant molecules in purpose-built high containment suites, covering film-coated tablets, soft-gel, and hard-shell capsules.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full EirGen Pharma company profile →
Eximia Research
HQ: United States
Website
- Description: Provider of multi-therapeutic clinical research site network services for biotech companies, conducting Phase I–IV clinical trials across therapeutic and diagnostic indications. Offers patient recruitment and engagement (including underrepresented populations), feasibility studies with investigator feedback, rapid site start-up and feasibility, regulatory and start-up support (contract and budget management), and quality assurance.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Eximia Research company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for AnalytiCon Discovery
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to AnalytiCon Discovery
2.2 - Growth funds investing in similar companies to AnalytiCon Discovery
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for AnalytiCon Discovery
4.2 - Public trading comparable groups for AnalytiCon Discovery
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →